Evofem Biosciences Stock Price

0.0091 (0.88%)
Upgrade to Real-Time
Regular Market
Volume 152,793
Bid Price 1.03
Ask Price 1.04
News -
Day High 1.05


52 Week Range


Day Low 1.01
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Evofem Biosciences Inc EVFM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0091 0.88% 1.0391 10:58:55
Open Price Low Price High Price Close Price Prev Close
1.04 1.01 1.05 1.03
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
451 152,793 $ 1.03 $ 158,127 - 0.1104 - 1.51
Last Trade Time Type Quantity Stock Price Currency
10:58:55 6 $ 1.035 USD


Draw Mode:

Evofem Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 13.21M 12.71M 12.53M $ 8.24M $ - -24.30 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 3.24M 2.20%

more financials information »

Evofem Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EVFM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.,518-0.0409-3.79%
1 Month0.21041.510.11040.24770973,273,3770.8287393.87%
3 Months0.42911.510.11040.3063153,075,8300.61142.16%
6 Months0.46241.510.11040.37694293,575,8640.5767124.72%
1 Year0.821.510.11040.76309385,294,6660.219126.72%
3 Years5.308.990.11041.653,255,097-4.26-80.39%
5 Years11.8112.560.11041.672,289,336-10.77-91.2%

Evofem Biosciences Description

Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Your Recent History
Evofem Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.